ArrowMark Colorado Holdings LLC 13D and 13G filings for C4 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-12 4:13 pm Sale |
2023-05-31 | 13G | C4 Therapeutics, Inc. CCCC |
ArrowMark Colorado Holdings LLC | 1,493,450 3.040% |
-4,309,421 (-74.26%) |
Filing |
| 2023-02-14 5:30 pm Purchase |
2022-12-31 | 13G | C4 Therapeutics, Inc. CCCC |
ArrowMark Colorado Holdings LLC | 5,802,871 11.850% |
389,143 (+7.19%) |
Filing |
| 2022-06-10 08:44 am Purchase |
2022-05-31 | 13G | C4 Therapeutics, Inc. CCCC |
ArrowMark Colorado Holdings LLC | 5,413,728 11.090% |
5,413,728 (New Position) |
Filing |